Journal article icon

Journal article

Emerging clinical experience with vaccines against group B meningococcal disease

Abstract:

The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era with the availability of two vaccines against capsular group B meningococcus (MenB). Both of these vaccines are based on sub-capsular proteins of the meningococcus, an approach that overcomes the challenges set by the poorly immunogenic MenB polysaccharide capsule but adds complexity to predicting and measuring the impact of their use.

This review describes the development and use of Men...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.vaccine.2017.07.056

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Research group:
Oxford Vaccine Group
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Research group:
Oxford Vaccine Group
Role:
Author
Publisher:
Elsevier Publisher's website
Journal:
Vaccine Journal website
Volume:
36
Issue:
36
Pages:
5470-5476
Publication date:
2017-08-01
Acceptance date:
2017-07-17
DOI:
EISSN:
1873-2518
ISSN:
0264-410X
Source identifiers:
708373
Keywords:
Pubs id:
pubs:708373
UUID:
uuid:6bec8316-f7ba-49c4-86db-1cea462146fd
Local pid:
pubs:708373
Deposit date:
2017-07-17

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP